IGF2BP1 has been linked to coronary artery disease (CAD) and T2DM, and it has been proposed as a potential therapeutic target in atherosclerosis and diabetic angiopathy [43, 44]. The gene discussed is IGF2BP1; the disease is diabetic peripheral angiopathy.